Oncogene activation of HIV-LTR-driven expression via the NF-kappa B binding sites
- PMID: 8255780
- PMCID: PMC310641
- DOI: 10.1093/nar/21.22.5229
Oncogene activation of HIV-LTR-driven expression via the NF-kappa B binding sites
Abstract
The Raf-1 proto-oncogene product is a highly regulated serine/threonine kinase that functions in signal transduction downstream from growth factor receptors and upstream from nuclear proto-oncogene products. Using a transient cotransfection assay we have found that activated Raf-1 activates expression from the HIV-LTR. Analysis of a series of 5' deletion and point mutations revealed the NF-kappa B motifs as the Raf-responsive element in the HIV-LTR. Moreover, Raf-BXB activated expression from heterologous promoters driven by the HIV NF-kappa B binding sites. In addition to Raf, we show that v-Src, v-H-Ras and v-Mos activate HIV-LTR expression through the NF-kappa B binding sites and v-H-Ras-induced HIV-LTR expression is mediated by Raf-1. These findings may have implications for the involvement of the cellular homologues of these oncogenes in the switch from latent to productive infection by HIV in response to T-cell activation.
Similar articles
-
Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.J Immunol. 1998 Jul 1;161(1):268-76. J Immunol. 1998. PMID: 9647233
-
The Ras-Raf pathway is activated in human immunodeficiency virus-infected monocytes and particpates in the activation of NF-kappa B.J Virol. 1996 Apr;70(4):2332-8. doi: 10.1128/JVI.70.4.2332-2338.1996. J Virol. 1996. PMID: 8642660 Free PMC article.
-
Differential regulation of the HIV-1 LTR by specific NF-kappa B subunits in HSV-1-infected cells.Virology. 1996 Oct 1;224(1):214-23. doi: 10.1006/viro.1996.0523. Virology. 1996. PMID: 8862416
-
Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1.J Biol Chem. 1993 Aug 25;268(24):17676-9. J Biol Chem. 1993. PMID: 8349650
-
Modulation of HIV-enhancer activity by heterologous agents: a minireview.Gene. 1991 May 30;101(2):165-70. doi: 10.1016/0378-1119(91)90407-3. Gene. 1991. PMID: 2055485 Review.
Cited by
-
Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway.J Virol. 1999 Apr;73(4):3460-6. doi: 10.1128/JVI.73.4.3460-3466.1999. J Virol. 1999. PMID: 10074203 Free PMC article.
-
RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.Mol Cell Biol. 1995 Aug;15(8):4260-71. doi: 10.1128/MCB.15.8.4260. Mol Cell Biol. 1995. PMID: 7623820 Free PMC article.
-
Binding of human immunodeficiency virus type 1 to CD4 induces association of Lck and Raf-1 and activates Raf-1 by a Ras-independent pathway.Mol Cell Biol. 1996 Nov;16(11):6532-41. doi: 10.1128/MCB.16.11.6532. Mol Cell Biol. 1996. PMID: 8887682 Free PMC article.
-
Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter.J Virol. 1996 Apr;70(4):2260-8. doi: 10.1128/JVI.70.4.2260-2268.1996. J Virol. 1996. PMID: 8642652 Free PMC article.
-
Raf induces NF-kappaB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation.Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4615-20. doi: 10.1073/pnas.080583397. Proc Natl Acad Sci U S A. 2000. PMID: 10758165 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous